Day: July 27, 2020

Acquisition of 92% of LCI Medical securities on July 24th, 2020Tripling of the size of Safe GroupSecond convocation for the Combined Annual General Assembly held on August 4th, 2020Eragny-sur-Oise, France, July 27th, 2020, 8h30 CEST – Safe Orthopaedics (FR0013467123 – ALSAF), a company specializing in the design and marketing of ready-to-use technologies for spinal surgeries, delivering the safest treatment of spinal fractures urgently treated, announces today the acquisition of 92% of LCI Medical securities and the second convocation for the Combined Annual General Assembly held on August 4th, 2020, to decide in particular on the share-based compensation for the contribution of the remaining LCI Medical securities.“Safe Orthopaedics acquires today the company LCI Medical, leading to the creation of an integrated industrial group...

Acquisition de 92% des titres de LCI Medical le 24 juillet 2020Triplement de la taille du groupe SafeSeconde convocation à l’Assemblée générale mixte le 4 août 2020  Eragny-sur-Oise, France, le 27 juillet 2020 à 8h30 CEST – Safe Orthopaedics (FR0013467123 – ALSAF), société́ spécialisée dans la conception et commercialisation de technologies prêtes-à-l ’emploi pour la chirurgie du dos, particulièrement sécurisantes pour les fractures vertébrales traitées en urgence, annonce aujourd’hui l’acquisition de 92% des titres de LCI Medical et la seconde convocation à une Assemblée Générale des actionnaires le 4 août 2020, statuant notamment sur la rémunération en actions de l’apport du solde des titres de LCI Medical.« Safe Orthopaedics acquière aujourd’hui la société LCI Medical, menant à la création d’un groupe industriel intégré du secteur...

Oslo, 27 July 2020Interoil is pleased to announce the reopening of Vikingo’s operation after its temporarily closure on 19 May 2020 due to the effects of the COVID-19 pandemic with the lock-in effect in place.  Since last Monday, 20 July 2020, Vikingo’s production has reached a stable flow of 250 barrels of oil per day.  This production represents a 25 per cent rate increase over Vikingo’s production prior to its shut-in. Production increase at reopening is promising and comes at odds at what is regularly assumed in a well reopening after a shut-in period as long as Vikingo’s closure, where it would be most likely to expect a small reduction in the flow rate when bringing the well back to production.  The fact that Vikingo’s production has stabilized with a 25 per cent positive increment is encouraging and indicative of a potential higher...

Suominen Corporation’s press release on July 27, 2020 at 9:30. a.m. (EEST) Suominen Corporation will publish its Interim report for January 1 – June 30, 2020 on Wednesday, August 12, 2020 at approximately 9:30 a.m. EEST.Conference call participants are requested to dial on:SE: +46 856 642 651UK: +44 333 300 0804US: +1 631 913 1422The confirmation code for joining the conference call is 56242138#.The event cannot be attended on the spot.Distribution:Nasdaq Helsinki Ltd.Main mediawww.suominen.fi

Suominen Oyj:n lehdistötiedote 27.7.2020 klo 9.30Lähetystä on mahdollista seurata osoitteessa https://suominen.videosync.fi/2020-q2. Lähetyksen tallenne ja esitysaineistot ovat saatavilla tilaisuuden jälkeen osoitteessa www.suominen.fi.Tilaisuuteen voi osallistua myös puhelinkonferenssin kautta. Puhelinkonferenssiin osallistutaan soittamalla numeroon 09 81 710 310 ja syöttämällä vahvistuskoodi 56242138#. Kysymykset tulee esittää englanniksi.Tilaisuutta on mahdollisuus seurata myös Twitterissä: twitter.com/SuominenOyjTilaisuuteen ei ole mahdollista osallistua paikan päällä.Suominen valmistaa kuitukankaita rullatavarana pyyhintätuotteisiin sekä muihin sovelluksiin. Visiomme on olla edelläkävijä innovatiivisissa ja vastuullisissa kuitukankaissa. Suomisen kuitukankaista valmistetut lopputuotteet, esimerkiksi kosteuspyyhkeet, terveyssiteet...

Good morning,Please find below the press release issued today.Best regards,Michele Moore DuhenGlobal PR Manager | Group Marketing & CommunicationsCapgemini Group | LondonTel.: +44 3709 053408Email: Michele.MooreDuhen@capgemini.com_____________________________Press contact:Florence LièvreTel.: +33 1 47 54 50 71Email: florence.lievre@capgemini.comGlobal citizens favor ‘smart cities’ and call for their hometowns to be sustainableUrban sustainability has become a consideration for citizens with 42% willing to leave their town due to pollution concernsOver a third of citizens are willing to pay for more enriched digital servicesSmart city initiatives are helping city officials manage the COVID-19 pandemicParis, July 27, 2020 – Today’s city living is falling short of citizens’ increased expectations in the digital age. This is according...

Bonjour,Vous trouverez ci-après le communiqué de presse diffusé ce jour.Bien cordialement,Florence LièvreGlobal PR Manager | Group Marketing & CommunicationsCapgemini Group | ParisTel.: +33 1 47 54 50 71Email : florence.lievre@capgemini.com_____________________Contact presse :Florence LièvreTél. : +33 (0)1 47 54 50 71E-mail : florence.lievre@capgemini.comLes citoyens à travers le monde plébiscitent les « villes intelligentes » et ont des attentes fortes en matière de développement durableL’urbanisme durable fait désormais partie des considérations des citadins, 42% d’entre eux se déclarant prêts à quitter leur ville en raison de préoccupations liées à la pollutionPlus d’un tiers des citadins sont disposés à payer plus pour des services digitaux enrichisLes initiatives de « Smart City1 » aident les villes à faire face à la pandémie...

TOKYO, July 27, 2020 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Japan K.K., a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce it has entered a Memorandum of Understanding (MOU) with ATOX Co., Ltd. (‘ATOX’), the exclusive Japanese sales agent for Belgium company IRE ELiT’s 68Ge/68Ga-generator. Under the terms of the MOU, ATOX will provide the 68Ge/68Ga-generator for use in a Phase I clinical study of Telix’s 68Ga-PSMA-11 kit for prostate cancer imaging in Japanese patients.Telix Pharmaceuticals Japan President Dr. Shintaro Nishimura stated, “Although the clinical utility of PSMA-11 for prostate cancer imaging is well understood worldwide and included in clinical practice guidelines1, to date no meaningful clinical research involving PSMA-11 has been undertaken in Japan....

Trondheim, 27 July 2020: NORBIT, a global provider of tailored technology to carefully selected niches, today announces that NORBIT Aptomar, part of segment Oceans, has been awarded a contract from an undisclosed customer in Asia for delivery of the SeaCOP eVTS system. The system is designed to be used for environmental and asset monitoring. The value of the order is approximately NOK 20 million.“We are very pleased to be able to also secure a contract for the SeaCOP system in Asia, proving the global market potential of this solution,” says Per Jørgen Weisethaunet, CEO of NORBIT.The SeaCOP eVTS system combines remote sensing technologies like radar, infrared cameras and sonars, with state-of-the-art data fusion and artificial intelligence. The purpose is to give the user a situational awareness, information and tools to increase efficiency...

ADLPartnerSociété anonyme à directoire et conseil de surveillance au capital de 6 478 836 euros3, avenue de Chartres 60500 – CHANTILLY393 376 801 R.C.S. CompiègneDéclaration des transactions sur actions propres réalisées du 20 au 24 juillet 2020Présentation agrégée par jour et par marchéDétail transaction par transactionRelations Investisseurs & Informations financièresTel : +33 1 41 58 72 03 – Courriel : relations.investisseurs@adlpartner.frADLPartner est cotée sur Euronext Paris – Compartiment CCodes ISIN : FR0000062978-ALP – Bloomberg : ALP FP – Reuters : ALDP.PAwww.adlpartner.comPièce jointeADLPartner_rachats_actions_28072020